Monthly Archives: December 2015

Top Ten Most Engaging LifeSciVC Posts Of 2015
December 28, 2015

As 2015 comes to a conclusion, it’s a good time reflect on the year’s progress – celebrating the wins, thinking through the losses, and learning from both. One specific reflection of late regards this blog: I’ve looked back at the

Leave a comment

Biotech New Venture Formation: Reflecting On A Decade’s Changing Dynamics
December 18, 2015

This year I celebrated my 10-year work anniversary with Atlas.  Hard to believe how fast a decade flies by, and this milestone triggered some reflections on how times have changed in biotech and the early stage venture business. As we

6 Comments

A Biotech New Year’s Resolution
December 15, 2015

This blog was written by Ron Renaud, CEO of RaNA Therapeutics, as part of the “From the Trenches” feature of LifeSciVC. It is that time of the year again when we start to get ready for the New Year.  It is

2 Comments

Seven Habits of Celgene’s Highly Successful Strategy
December 10, 2015

Over the past seven years, Celgene has emerged as one of the most active and creative deal-makers in the biopharma industry. The Boston Consulting Group’s Biopharma Partnering Survey and Benchmarking analysis examines BD activity and perceptions across the industry, and

Leave a comment

Setting The Pace In The Race To Treat NASH
December 9, 2015

This blog was written by Rosana Kapeller, CSO of Nimbus Therapeutics, as part of the “From the Trenches” feature of LifeSciVC. It is the holiday season and as we gorge on delicious and heavy food, and inevitably resolve to eat less

7 Comments

Building The Pipeline In Small Biotech: Managing Risk And Reward
December 3, 2015

This blog was written by Ankit Mahadevia, CEO at Spero Therapeutics, as part of the “From the Trenches” feature of LifeSciVC. In my experience, looking to the outside world for new pipeline ideas isn’t just the realm of larger companies.   The

Leave a comment